BioSniper
ZH
Toggle language
Open menu
Earnings Report
positive
Earnings Report
May 6, 2026
Company
Castle Biosciences Inc. (CSTL)
Other upcoming events for CSTL
Phase 3 Readout
Phase 3 Topline: A Pivotal Phase 3 Study of FCX-007 (Genetically-Modified Autologous Human Dermal Fibroblasts) for Re
Jul 1, 2037
Phase 3 Readout
Phase 3 Topline: Evaluation of Dabocemagene Autoficel (D-Fi; FCX-007; Genetically Modified Autologous Human Dermal Fi
Feb 1, 2042
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Start Free
Full Calendar
CSTL Overview
PDUFA Dates
Phase 3 Readouts
Earnings Report — CSTL Earnings Report | BioSniper